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Abstract
The overwhelming amount of available scholarly literature in the life sciences poses significant challenges to scientists
wishing to keep up with important developments related to their research, but also provides a useful resource for the
discovery of recent information concerning genes, diseases, compounds and the interactions between them. In this paper,
we describe an algorithm called Bio-LDA that uses extracted biological terminology to automatically identify latent topics,
and provides a variety of measures to uncover putative relations among topics and bio-terms. Relationships identified using
those approaches are combined with existing data in life science datasets to provide additional insight. Three case studies
demonstrate the utility of the Bio-LDA model, including association predication, association search and connectivity map
generation. This combined approach offers new opportunities for knowledge discovery in many areas of biology including
target identification, lead hopping and drug repurposing.
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Introduction
Translational research in medicine is concerned with trans-
forming basic laboratory science into effective patient therapies as
quickly as possible. Developing effective treatments requires a
cross-discipline understanding of medicine, pharmacology, biol-
ogy and chemistry at the physiological, cellular, and molecular
levels. Probably the most significant source of knowledge lies as
text in published literature. PubMed [1] is an online resource that
provides more than 19 million citations for published articles in
journals and books, and while most are associated with short
abstracts, an increasing number are now being accompanied by
free, full text articles. At the same time, sophisticated interdis-
ciplinary research has lead to the development and application of
powerful methods to generate enormous amounts of new data
resulting in an increased topical complexity of research articles.
This complexity makes it challenging to efficiently discover,
evaluate and synthesize the latest information, trends, and
findings deposited in published literature in a reasonable amount
of time. For the biomedical researcher, being able to quickly
generate and ascertain the significance of associations between
chemicals, genes and diseases are valuable in investigations
relating to drug discovery. Thus, generating useful approaches to
facilitate knowledge discovery through systematic analysis of
abstracts and full-text journal articles is an important and
ongoing challenge.
Natural language processing (NLP) is a common approach to
text mining of biomedical corpora [2,3]. However, NLP largely
relies on the syntactic and linguistic structure of documents, and
is not in itself able to identify scientific relationships between
terms. In contrast, statistical modeling techniques including
Latent Dirichlet Allocation (LDA) [4] make the automated
identification of topics from large document collections and
corpora possible [5]. LDA, a hierarchical Bayesian model, has
been extended to obtain relations between topics and terms [6].
Having a specialized and advanced LDA model using life sciences
terms may provide a more effective way of exploring the
biomedical literature.
Despite enormous investments in generating information
pertinent to drug discovery and disease research, the problems
associated with data integration are still a barrier to medical
research [7]. An important tool in breaking down this barrier is the
Semantic Web. Using Semantic Web technologies it becomes
possible to convert data to a common syntax and specify the
meaning of the data through shared vocabularies that can be
specified as a formal, logical-based ontology. Bio2RDF [8],
Chem2Bio2RDF[9], and Linked Open Drug Data (LODD) [10]
are all projects involved in providing life sciences data using
Semantic Web technologies. The resulting cloud of Linked Open
Data now makes it possible to download interlinked data in a
common format and the ability to query across their diverse
resources, such resources are likely to become powerful drivers for
increasing scientific productivity. Clearly, being able to link these
datasets with complementary extracted information from the
PubMed datasets would dramatically increase the overall oppor-
tunity for knowledge discovery.
The LDA model considered in this paper is a model for a text
corpus viewed as a collection of bags of words. It assumes that
people write an article with several topics in mind; each topic is
associated with a different conditional distribution over a fixed set
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generated by the same set of topics with different probability
distribution for each document [4,11]. Therefore, LDA is a
mixture model, i.e., the mixture components are shared across all
documents but each document exhibits different mixture propor-
tions [4].
Since Blei et al. introduced the LDA model [4], various extended
LDA models havebeenused in automatictopic extraction from text
corpora. Rosen-Zvi et al. introduced the Author-Topic model
which extended LDA to include authorship [5]. Each author is
associated with a multinomial distribution over topics. They applied
the model to a collection of 1,700 NIPS conference papers and
160,000 CiteSeer abstracts. The primary benefit of the author-topic
model is that it allows the explicit inclusion of authors in the
document models, providing a general framework for answering
queries and making predictions at the level of authors as well as the
level of documents. Based on Author-Topic model, McCallum and
Wang presented anAuthor-Recipient-Topic (ART) modelforsocial
network analysis, which learns topic distributions based on the
direction-sensitive messages sent between entities, adding the key
attribute that distribution over topics is conditioned distinctly on
both the sender and recipient [12]. Tang et al. further extended the
LDA and Author-Topic model to the Author-Conference-Topic
model [6], which is considered as a unified topic model to
simultaneously model the different types of information in the
academic network. They found that the proposed method had a
high performance in expertise search and association search.
Xiance and Maosong proposed a tag-LDA model which extended
LDA model by adding the tag variable and applied it to social
tagging systems [13].
In addition to text data, adapted LDA models are also applied
to visual data for topic mining. In order to refine tags associated
with images, Xu et al. proposed a regularized LDA (rLDA) which
facilitates the topic modeling by exploiting both the statistical of
tags and visual affinities of images in the corpus [14]. Wang and
Grimson proposed a topic model Spatial Latent Dirichlet
Allocation (SLDA), in which the knowledge of spatial structure
can be flexibly added as a prior, grouping visual words which are
close in space into the same document [15]. They found that
SLDA achieved better performance than LDA when applied to a
collection of images.
Those studies above extended the classic LDA model mainly by
incorporating new variables to meet the customized demand in the
applied area. Other advanced extensions of LDA model include
supervised Latent Dirichlet Allocation (sLDA) [16] and dynamic
topic model [12].
Some prior studies have been devoted to multiple alternatives of
speeding up the learning of LDA, including parallelization across
machines. Newman and et al. presented two synchronous
methods, AD-LDA and HD-LDA, to perform distributed Gibbs
sampling [17]. Asuncion, Smyth and Welling proposed asynchro-
nous distributed learning algorithms for LDA and Hierarchical
Dirichlet Process (HDP) in which processors independently
perform Gibbs sampling on their local data and communicate
their information in a local asynchronous manner with other
processors [18]. Wang et al. introduced a parallel implementation
of LDA on MPI and MapReduce, which smoothes out storage and
computation bottlenecks and provides fault recovery for lengthy
distribution computation [19].
As for applications of LDA in biomedical domain, Blei et al.
examined 5,225 free-text items in the Caenorhabditis Genetic
Center (CGC) Bibliography using the classic LDA model [20].
They found that like other graphical models for genetic, genomic
and other types of biological data, the LDA model estimated from
CGC items had better predictive performance than two standard
models (unigram and mixture of unigrams) trained using the same
data. Zheng, et al. applied the classic LDA model to a corpus of
protein-related MEDLINE titles and abstracts and extracted 300
major topics [21]. They found that those topics were semantically
coherent and most represented biological objects or concepts.
They further mapped those topics to controlled vocabulary of the
Gene Ontology (GO) terms based on mutual information. They
concluded that those identified topics provide parsimonious and
semantically-enriched representation of the texts in a semantic
space with reduced dimensionality that can be used to index text.
Bundschus et al. presented a Topic-Concept model, which extends
the basic LDA framework to reflect the generative process of
indexing a PubMed abstract with terminological concepts from an
ontology [22]. The Topic-Concept model extends the LDA
framework by simultaneously modeling the generative process of
document generation and the process of document indexing. For
each of the concepts in the document a topic is uniformly drawn
based on the topic assignments for each word in the document;
each concept is sampled from a multinomial distribution over
concepts specific to the sampled topic. They applied the model
into a large-scale collection of medical text from PubMed and
found that a number of important tasks for biomedical knowledge
discover can be solved with Topic-Concept model.
While previous applications of LDA in the biomedical domain
have yielded several benefits, few considered the extension of the
LDA model to include bio-terms (that is a restricted vocabulary of
genes, compounds, diseases, and so on) as input parameters. In this
paper, we develop a Bio-LDA model, which extends the LDA
model by incorporating bio-terms as input variables to the classic
LDA model. The associations of the bio-terms are measured based
on the topic distribution of the bio-terms. This approach is useful
to establish hidden relations between biomedical concepts from
literature compare to the commonly used co-occurrence-based
methods [23,24]. The identified bio-term associations are
evaluated using Chem2Bio2RDF.
Our contributions are: 1) the development of Bio-LDA, a novel
advanced LDA model to mine the latent semantics among topics
and biological terms; 2) conversion of identified latent semantics to
RDF triples and alignment with existing semantic life data; 3) the
demonstration of the application of these methods through use
cases which cannot be solved by using traditional literature and
database searches. This paper is organized as follows: Section 2
covers the data and methodology, the proposed Bio-LDA model,
and other related tools/services built using this model. Section 3
presents the experimental results of the Bio-LDA model and
describes three use cases to illustrate the utility of the approach in
solving interesting problems in biomedical domain and section 4
offers our summary discussion.
Materials and Methods
Datasets
Chem2Bio2Rdf. Chem2Bio2RDF[9] consists of about 78
million RDF triples over 25 datasets relating to systems chemical
biology, which is grouped into 6 domains, namely chemical
(PubChem Compound, ChEBI, PDB Ligand), chemogenomics
(KEGG Ligand, CTD Chemical, BindingDB, MATADOR,
PubChem BioAssay, QSAR, TTD, DrugBank, ChEMBL, Binding
MOAD,PDSP,PharmGKB),biological(UNIPROT,HGNC,PDB,
GI), systems (KEGG Pathway, Reactome, PPI, DIP), phenotype
(OMIM, Diseasome, SIDER, CTD diseases) and literature
(MEDLINE/PubMed. Provenance information pertaining to these
resources is available at http://chem2bio2rdf.org/datasets.html.
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owl:sameAs.
MEDLINE and Bio-Terms Extraction. PubMed offers a
web-based and programmatic search service over its content [1].
However, this interface is limited to small- to medium-scale
queries, and text mining using this interface is not possible.
MEDLINE is the primary component of PubMed, where
approximately 5400 biomedical journals published in the United
States and worldwide, and covers abstracts from 1949 to present.
The entire content of MEDLINE is available as a set of text files
formatted in XML (eXtensible Markup Language). In this project,
the 2010 MEDLINE/PubMed baseline database is used as our
primary data source, which contains 617 files and 18,502,916
records (which covers citations through 2010).
In order to support our information extraction and text mining,
we developed a system to load MEDLINE XML files to a relational
database,extracting bio-terms from MEDLINE,and converting the
relational database to RDF schema as shown in Figure 1.
The relational database schema used in our system is designed
based on the category of bio-terms (compound, drug, gene, disease,
side-effect, pathway) and DTD (Document Type Definition) provided
by National Library of Medicine (N L M ) .C o n s i d e r i n gt h es i z eo f
MEDLINE database (over 18 million citations), we tried to minimize
lookups by introducing redundant information in database. Our
MEDLINE database contains several tables: medline_citation contains
the title, abstract information, medline_biblio contains the bibliography
information, medline_author contains the authors’ information, medli-
ne_comp contains the mentioned compounds in the citation, etc. All
tables contain a PubMed identifier (PMID) in one column, which
connects tables and is also the key attribute in the RDF conversion.
Information such as citation, authors, journals, MeSH terms
were directly parsed from the XML file and loaded into
database. The bio-terms information needs to first apply
extraction method to intermediate files and then load to
database. In our system, we used the dictionary extraction
method. Bio-term dictionaries are generated from the following
data sources listed in Chem2Bio2RDF: the compound dictio-
nary is generated from PubChem Synonym with the PubChem
Compound identifier (CID); the drug dictionary is generated
from DrugBank and used DBID as the identifier; the gene
dictionary is generated from the HGNC and used UniprotID as
the identifier; the disease dictionary is generated from the CTD
(the comparative toxicogenomics database) and used MeshID as
the identifier; the side effect dictionary is generated from the
Sider and used UMLSID as the identifier; the pathway
dictionary is generated from the KEGG pathway and used
KeggID as the identifier. The extraction tools parses the XML
file and extracts the terms based on the pre-generated
dictionaries, then saved the results to intermediate flat files,
and then loads the files into the database. Table 1 summarizes
the dictionary attributes.
The D2R tool [25] is used to convert to the MEDLINE
relational database to RDF schema and combined to the
Chem2Bio2Rdf [9], which supports data visualization and
complex query retrievals. The key attribute for the MEDLINE
triples is the PMID. The extracted bio-terms, which used the well-
Figure 1. Data Preprocessing.
doi:10.1371/journal.pone.0017243.g001
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sources, i.e. PubChem, UniProt, etc.
Bio-LDA
The Bio-LDA model extends the ACT model [6] and
emphasizes on bio-terms occurred in literatures. The basic
assumption of the Bio-LDA model is that bio-terms of a paper
would determine topics written in this paper and each topic then
generates the words and determines the publication journal. The
generative process can be summarized in the Figure 2:
1. For each bio-term x=1, … , B, draw hx , Dirichlet(a)
For each topic z=1, …, T, draw wz , Dirichlet(b), and yz ,
Dirichlet(m)
2. For each document d = 1, …, D
Given the vector of bio-terms bd
For each word wi in document d:
Draw a bio-term xdi , Uniform(bd)
Draw a topic zdi , Dirichlet(hxdi)
Draw a word wdi , Dirichlet(wzdi)
Draw a journal jdi , Dirichlet(yzdi)
In this model, the number of possible topics T is fixed. Three
continuous random variables, h, w, and y, are involved in this
model. For a given set of documents, D
train, our aim is to estimate
the posterior distribution of those continuous random variables.
Our inference scheme is based on the observation that
P(h,w,yjDtrain,a,b,m)~
X
z,x
P(h,w,yjz,x,Dtrain,a,b,m)P(z,xjDtrain,a,b,m) ð1Þ
In the training process, an empirical sample-based estimation of
P(z,xjDtrain,a,b,m) is first obtained using Gibbs sampling.
P(zdi,xdijz{di,x{di,w,j,a,b,m)!
m{di
xdizdizazdi P
z (m{di
xdizzaz)
n{di
zdiwdizbwdi P
wv (n{di
zdiwvzbwv)
n{d
zdijdzmjd P
j (n{d
zdijzmj)
ð2Þ
where the superscript -di denotes a quantity, excluding the current
instance (e.g., the di-th word token in the d-th paper). After Gibbs
sampling, the probability of a word given a topic w, the probability
of a journal given a topic y, and the probability of a topic given a
bio-term h can be estimated as follows:
wzwdi~
n{di
zdiwdizbwdi P
wv (n{di
zdiwvzbwv)
ð3Þ
yzjd~
n{d
zdijdzmjd P
j (n{d
zdijzmj)
ð4Þ
hxz~
mxzzaz P
z0 (mxz0zaz0)
ð5Þ
With the estimated continuous random variables, h, w, and y,
we can identify the information content of bio-terms, and find
association among bio-terms.
Bio-term Entropy over Topics. In information theory,
entropy is a measure of the uncertainty associated with a
random variable. It is also a measure of the average information
content. In our Bio-LDA model, we can compute the bio-term
entropies over topics as shown in equation 6, which indicates that
bio-terms tend to address a single topic or cover multiple topics.
The higher the entropy is, the more diverse the bio-term is over
topics.
Entropy(bi)~{
X T
z~1
hbiz loghbiz ð6Þ
Semantic Association of Bio-Terms. Kullback-Leibler
divergence (KL divergence) is a non-symmetric measure of
the difference between two probability distributions. In our Bio-
LDA model, we used the KL divergence as the non-symmetric
distance measure for two bio-terms over topics, as shown in
equation 7.
Table 1. Statistics of the bio-terms extraction.
Bio-Terms
# of unique
terms
# of term-
citation pairs
# of unique
citations
Compound 56,383 11,775,891 5,856,084
Drug 2,820 5,624,529 3,427,067
Gene 13,022 5,252,844 3,735,517
Disease 3,848 12,612,636 7,066,084
Side Effect 1,363 10,489,676 6,310,741
Pathway 180 916,754 838,090
doi:10.1371/journal.pone.0017243.t001
Figure 2. Graphical representation of the Bio-LDA models.
doi:10.1371/journal.pone.0017243.g002
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X T
z~1
hbiz log
hbiz
hbjz
ð7Þ
The symmetric distance measure of two bio-terms over topics is
the sum of two non-symmetric distances, as shown in equation 8.
sKL(bi,bj)~
X T
z~1
(hbiz log
hbiz
hbjz
zhbjz log
hbjz
hbiz
) ð8Þ
In this study, the direction of the associations is not considered.
We only focus on the association score calculated by the symmetric
distances unless user specified to use the non-symmetric distances.
Other implemented tools
In our Bio-LDA model, the association of two bio-terms in the
literature can be measured use the KL-divergence. The smaller
the score is, the stronger the association is. This association score
can combined with the pre-knowledge of bio-terms (i.e. Chem2-
Bio2Rdf) for novel knowledge discovery.
Association Predication. Two Bio-terms can be associated if
there is a path between them or two bio-terms have similar
chemical or biological activities. The graph definition of three
types of semantic association is shown in Figure 3 [26]. However,
the number of association pairs is usually very large for the big
network. The association score from bio-LDA model can be used
to rank and select the most interest pairs from the candidate pool.
In Chem2Bio2RDF, there are eight kinds of relations: compound-
compound, compound-gene, compound-disease, compound-side effect, compound-
pathway, gene-gene, gene-disease, and gene-pathway. For a given source, it
is quite easy to find its associated target with a given type in
Chem2Bio2RDF. For instance, finding compounds that target
genes can be done by finding the direct relation among compound-
gene pairs. However, users are usually not only interested in those
already known links but also want to get information about the
possible indirect links. Indirect relations through an intermediary
also offer an opportunity to find linked compound-gene relations (r-
path association). The relations can then be validated using the
calculated association scores from the Bio-LDA topic model. For
instance, in order to find the possible in-directed linkage for a given
gene-compound pair, we can look up the four extended associations
in Chem2Bio2RDF: gene-disease-compound, gene-compound-compound,
gene-pathway-compound, and gene-gene-compound, and then compute the
association scores for the outputs from Chem2Bio2RDF. A valid
extended association is defined as following:
sKL b1,b2 ðÞ ƒcT
Association b1,b2 ðÞ
 
[^ R RT b1,b2 ðÞ ð 9Þ
where association(b1,b2) indicates that possible semantic r-associa-
tions from Chem2Bio2RDF, sKL(b1,b2) is the association score
calculated using the Bio-LDA model described in section 3.2.2.
Association Search. In the area of network analysis, the task
of association search can be formalized as a task of path find in
graph. In our study, we are given a semantic network (e.g.,
Chem2Bio2RDF), which can be represented as a graph G =( V,
E), where vMV represents an entity (e.g., drug and gene) in the
network; e
r
ijME represents a relationship with property r (e.g., drug-
target interaction) between entities vi and vj; the relationship can be
directional or bi-directional; the goal of association search is to find
relationship sequences from vi to vj. We assume that no entity will
appear on a given association more than one time. We then define
the process of association search from one entity to the other as:
Given an association query (vi, vj), where vi denotes the source entity and vj
denotes the target entity. Association search is to find possible associations
{ak(vi, vj)} from vi to vj.
There are two subtasks along with association search: finding
possible associations between two bio-terms and ranking the
associations. In this work, we formalize the association search
problem as that of near-shortest associations search. We used a
two-stage approach for finding the near-shortest associations for
an association query (vi, vj):
1. Shortest association finding. It aims at finding the shortest
associations from all entities vMV\vj in the network to the target
entityvj (including the shortest association from vi to vj with length
Lmin). In a graph, the shortest path between two nodes can be
found using a heap-based Dijkstra algorithm to quickly find the
shortest associations that can achieve a complexity of O(nlogn).
2. Near-shortest associations finding. Based on the length of
shortest association Lmin and a pre-defined parameter b, the
algorithm requires enumeration of all associations that are less
than (1+b)Lmin by a depth-first search. We constrain the length
Figure 3. Semantic Association.
doi:10.1371/journal.pone.0017243.g003
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length restriction can reduce the computational cost.
The obtained associations are then ranked according to the
accumulated KL-divergence scores obtained from the Bio-LDA
model (eq. 8).
Connectivity Map Generation. The concept of molecular
connectivity maps is gaining an increased popularity in systems
chemical biology [27], which can help researchers to study and
compare the molecular therapeutic/toxicology profiles of many
candidate drugs. In this work, we proposed a computational
approach to build interest-specific connectivity maps, i.e. build
disease-specific gene-drug connectivity maps, based on both the
genomic data sources and the literature resources. The input query
for the connectivity map is ((vi, t), t1,t 2), where (vi, t) is the specified
bio-termand its type (e.g. Alzheimer’s Disease, Disease), t1 and t2 are
the bio-term types that formed the connectivity maps (e.g., drug and
gene). In this study, the candidate bio-terms for t1 are identified and
refined based on the genomic data sources in Chem2Bio2Rdf and
the candidate bio-terms for t2 are those that could interact to the
candidate bio-terms for t1. Their connection scores are given: the
linkage in Chem2Bio2Rdf, the association score calculated based on
the Bio-LDA model (equation. 8). Here, we used the disease-specific
gene-drug connectivity map as an example to show the process:
1. Specify a disease
2. Identify the genes that related to the given disease from prior
knowledge (i.e. Chem2Bio2Rdf).
3. Expand the genes based on the gene-gene interaction. This
step can be ignored if user does not want to count the protein-
protein interaction.
4. The genes identified from step 2 and 3 are combined and re-
ranked.
5. Find the drugs that can target one or more genes from the gene
set given by step 4. The drugs are ranked based on an
accumulated score of the importance of the targeted genes.
6. Calculate the association score based on the Bio-LDA model
for the gene set from step 4 and the drug set from set 5 to form
the connectivity maps.
Results
Analyzing the Bio-LDA Model Results
In our experiments, we applied the Bio-LDA model to 336,899
MEDLINE abstracts (, 330M in size) published in 2009, which
contains 308686 words, 13338 extracted bio-terms (only drug,
gene, disease are considered in this experiment), and 4450
Table 2. Representations for selected topics.
Topic 13 Topic 14
Word Prob Word Prob
patient 0.0177 patient 0.0231
transplant 0.0149 liver 0.0129
platelet 0.0074 hepat 0.0126
studi 0.0066 diseas 0.008
group 0.0063 studi 0.007
donor 0.0058 treatment 0.0063
factor 0.0056 result 0.0059
risk 0.0054 group 0.0057
result 0.0053 hcv 0.0056
graft 0.0053 associ 0.0052
Bio-Terms type Prob Bio-Terms type Prob
Thrombosis DISEASE 0.0855 Hepatitis C DISEASE 0.0883
Venous Thromboembolism DISEASE 0.0449 Colitis DISEASE 0.0784
Heparin DRUG 0.0417 Hepatitis B DISEASE 0.0511
Tacrolimus DRUG 0.0402 Hepatitis DISEASE 0.0467
Cyclosporine DRUG 0.0338 Fibrosis DISEASE 0.0383
VWF GENE 0.0335 Fatty Liver DISEASE 0.0274
Thrombocytopenia DISEASE 0.0274 Ribavirin DRUG 0.0258
Mycophenolate mofetil DRUG 0.0259 Liver Cirrhosis DISEASE 0.0236
IMPACT GENE 0.0225 Gastroesophageal Reflux DISEASE 0.0229
ABO GENE 0.0223 Irritable Bowel Syndrome DISEASE 0.0222
Journal Prob Journal Prob
Transplant. Proc. 0.0734 Hepatology 0.064
Transplantation 0.0721 World J. Gastroenterol. 0.0553
Thromb. Haemost. 0.0431 Am. J. Gastroenterol. 0.0532
Thromb. Res. 0.0428 Gastroenterology 0.0477
Transfusion 0.0412 Liver Int. 0.0394
doi:10.1371/journal.pone.0017243.t002
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The output includes the estimated parameters, h, w, and y, and
the top term lists of words, bio-terms and journals for each topic.
We created different models with 50, 100 and 200 topics. No
significant improvement was found with increased numbers of
topics. Thus, we used 50-topics model to optimize efficiency.
Examples of two topics (out of 50 topics in total) with the top 10
representative words, top 10 associated bio-terms, and top 5
related journals are listed in Table 2. The Bio-LDA model
provides an unsupervised method for extracting an interpretable
representation from a collection of documents. As shown in the
Table 2, the topic 13 is related to organ transplant and all of the
highest probability BioTerms for topic 14 are highly related to
liver disease (hepatitis). Our Bio-LDA model used the bio-terms,
journal information and the word information to characterize the
topic providing a better representation of topics than the simple
LDA model, which only can provide the word representation
Table 3 shows a table with the most associated topics for 3 of
13,338 possible bio-terms. The first bio-term, tuberculosis, is an
infectious lung disease caused by various strains of mycobacterium.
Topic 21 is the majority topic associated with tuberculosis with a
conditional probability of 0.8024 and very low probabilities for all
other topics. TNF, tumor necrosis factor, are almost equally
distributed to topic 33 and 38, with probability of 0.5203 and
0.4149. The last bio-term, cholesterol, is a waxy steroid metabolite
found in the cell membranes and transported in the blood plasma of
all animals. The topics associated with this drug are quite intuitive.
The word representations of topics provide an overview of the
published literature. Research trends over time could be discovered
byapplying the Bio-LDA topic modelondifferentyears individually
and comparing results (looking for emerging topics).
Comparing the Bio-LDA and LDA models
We chose the top 20 representative words for all 50 topics and
computed the word frequency based on the Bio-LDA model and
the general LDA model. As shown in Table 4a, 635 distinct words
are used to represent topics for LDA model and 354 distinct words
for Bio-LDA model. 462 words only appeared once in the top 20
topic words for the LDA model and 234 words for the Bio-LDA
model. It is shown that Bio-LDA tended to use fewer words to
represent topics.
In order to compare the output, we mapped the topics
generated using the LDA model with the topics generated using
the Bio-LDA model. To map the Bio-LDA model to the LDA
model, we searched the top 20 words for all topics in the LDA
model for each topic in the Bio-LDA model. The topic with the
highest number of shared words is considered as the mapped topic
in the LDA model. As shown in Table 4b, the 50 topics in the Bio-
LDA are mapped to 25 topics in the LDA. Only 17 topics in the
Bio-LDA model can mapped to unique topics in the LDA model.
The reverse mapping gave better performance. The 50 topics in
the LDA model can be mapped to 39 topics in the Bio-LDA
model. About 30 topics have unique mappings. Table 5 shows
three mapping examples of mapping LDA to Bio-LDA. Topic 30
in the LDA model is mapped to topic 25 in the Bio-LDA model;
topic 41 is mapped to topic 33, and topic 25 is mapped to topic 38.
There are 11 common words for each mapping.
Identification of Bio-Term Relationships within Topics
In the biomedical literature, bio-terms (drug names, gene
names, diseases, etc.) play an important role in determining the
topics. The Bio-LDA model makes direct use of bio-terms to
improve the overall topic generation and word association. As
shown in Table 6, only 55 words (5 drugs, 17 genes, and 33
diseases) are bio-terms among the 635 unique words (Table 7a)
generated from the top 20 words of the 50 topics in the LDA
model contains only. There are 66 bio-terms (9 drugs, 17 genes,
and 40 diseases) among the 354 unique words in the Bio-LDA
model. The top 20 bio-terms associated with topics are also output
for our Bio-Terms. Thus, significant number of bio-terms can be
identified in the Bio-LDA model. As shown below, 663 distinct
bio-terms, including 145 drugs, 150 genes, and 368 diseases are
identified.
We assume that there exists a weak topic related association if
the bio-terms are in the top list of a topic. Figure 4 illustrates an
association network drawn from the top 5 terms from 6 selected
Table 3. Top topics for the selected bio-terms.
BioTerm = Tuberculosis (Disease)
P(z|b) Topic Words
0.8024 21 infect, hiv, patient, vaccin, studi, case, tuberculosi, result, year, risk
0.0841 12 gene, protein, cell, express, strain, infect, pathogen, these, host, respons
0.0594 29 protein, bind, activ, structur, cell, domain, interact, these, membran, site
BioTerm = TNF (Gene)
P(z|b) Topic Words
0.5203 33 cell, express, inflamm, activ, inflammatori, induc, increas, alpha, effect, level
0.4149 38 cell, express, activ, immun, respons, induc, mice, cd4, receptor, these
0.0341 30 cell, activ, effect, induc, rat, studi, increas, oxid, level, express
BioTerm = Cholesterol (Drug)
P(z|b) Topic Words
0.3314 31 weight, obes, studi, associ, risk, women, children, group, bodi, increas
0.2926 33 cell, express, inflamm, activ, inflammatori, induc, increas, alpha, effect, level
0.1072 36 insulin, diabet, patient, glucos, level, studi, type, increas, associ, result
doi:10.1371/journal.pone.0017243.t003
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lines indicate the generated relationships are proofed by
Chem2Bio2RDF (i.e. there is a relationship in one of the
Chem2Bio2RDF datasets that confirms the literature relationship).
The dashed lines indicates the generated relationships have not
been found in Chem2Bio2Rdf, perhaps indicating very recent
findings which are not yet encoded in databases, or associations
which are not direct enough to be in a dataset. For instance, our
Bio-LDA model suggested that there might be protein protein-
protein interactions between CCND1 and EGFR, since both of
them are important targets in the tumor related diseases:
Carcinoma and Melanoma. It also suggested that EGFR may
also be target for Melanoma, although the linked database does
not mention it.
Discovery of Bio-Term Associations
In traditional text mining, bio-term association is usually
calculated based on the literature co-occurrence of those two
terms (Li J, et. al, 2008):
H(bi,bj)~ln(df(bi,bj)   Nzl){ln(df(bi)   df(bj)zl) ð10Þ
Here, df(bi) and df(bj) are the number of documents in which
bio-terms bi and bj are mentioned, respectively, df(bi,bj) are the
total number of documents in which both bio-terms are co-
mentioned in the same document. N is the size of the document
collection. l is a small constant (l=1 here) introduced to avoid
out-of-bound errors if any of df(bi,bj), df(bi) or df(bj) values are 0.
The H(bi,bj) representing the connections between the two bio-
terms. It is positive when the potential pairs are over-represented
and negative when the pairs are under-represented. The higher
the H(bi,bj) is, the more significant the two bio-terms are
connected.
However, a big limitation of this method is that it cannot
detect association between two bio-terms if they are not
involved in the same document. For example, the HTR1A
and HTR2A both do not appear in same abstracts as
Venlafaxine based on the PubMed collection. So the calculated
association scores are negative as shown in table 7, which
means there shouldn’t be any association between Venlafaxine
and HTR1A or HTR2A. However, we known that Venlafaxine
is used in the treatment of mental disorder, e.g. depressive
disorder and anxiety disorder. HTR1A and HTR2A have also
been studied in relation to mental disorders. So, in reality, there
must be certain association between Venlafaxine and HTR1A
and HTR2A.
To cover the drawbacks of this co-occurrence based method,
a better association approach based on the Bio-LDA topic model
is used. In the Bio-LDA model, venlafaxine, HTR1A and
HTR2A are all signed to topic 10, which focus on research on
mental diseases (top 5 word representation of topic 10 are
patient, studi, depress, schizophrenia, and treatment). The
calculated association score between venlafaxine and HTR1A
is quite small, indicating a very strong association between
venlafaxine and HTR1A. It is also in agreement with our
previous explanation.
Table 4. a) Frequency word sets of LDA model and Bio-LDA
model. b) Mappings between Bio-LDA model and LDA model.
Bin LDA Bio-LDA Bin BioLDA2LDA LDA2BioLDA
1 462 234 1 17 30
2 100 52 2 2 7
33 22 2 32 2
41 91 1 42 0
58 2 50 0
64 0 60 0
72 4 71 0
81 4 81 0
90 4
10 4 2
.10 3 19
SUM 635 354 SUM 25 39
(a) (b)
doi:10.1371/journal.pone.0017243.t004
Table 5. Compare word representation of topics in the Bio-
LDA model to topics in the LDA model.
30,–.25 41,–.33 25,–.38
LDA Bio-LDA LDA Bio-LDA LDA Bio-LDA
cell cell alpha cell cell cell
induc cancer factor express respons express
apoptosi express inflammatori inflamm immun activ
line tumor induc activ antibodi immun
effect activ beta inflammatori specif respons
human gene endotheli induc antigen induc
inhibit protein increas increas anti mice
death induc inflamm alpha gamma cd4
growth human express effect lymphocyt receptor
prolifer growth activ level ifn these
activ inhibit effect mice cd4 cytokin
vitro studi tnf protein induc human
p53 effect vascular factor product specif
result result growth studi activ regul
increas associ role tnf cytokin function
cycl line cytokin cholesterol human antigen
caspas these macrophag result against infect
treatment apoptosi mmp role receptor role
tumor breast tissu receptor cd8 mediat
vivo regul matrix these system signal
doi:10.1371/journal.pone.0017243.t005
Table 6. Bio-terms associated with topics.
Top 20 LDA Bio-LDA
words words bio-terms
Drug 5 9 145
Gene 17 17 150
Disease 33 40 368
bio-terms 55 66 663
doi:10.1371/journal.pone.0017243.t006
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our Bio-LDA model in discovering the bio-term associations, the
bio-term pairs in Chem2Bio2Rdf are used as the gold standard. As
shown in table 8, only few bio-term pairs are identified using the
co-occurrence method. The KL-divergence method based on the
Bio-LDA model can identify a much larger number of association
pairs. The cut-off for co-occurrence method is 0 and the cut-off for
Bio-LDA model is 5.
Identifying Potential Drugs for a Target
As discussed in section 3.3.1, we can generate bio-term
associations by combining the linked data resources (i.e.
Chem2Bio2Rdf) and literature resources (Bio-LDA model). To
illustrate, we investigated drugs that target the abelson murine
leukemia viral oncogene homolog 1 (ABL1), which has been
implicated in processes of cell differentiation, cell division, cell
adhesion, and stress response. ABL1 is also known as a factor in
chronic myeloid leukemia. As shown in Figure 5, five drugs,
cisplatin, adenesine triphosphate, imatinib, dasatinib, and gefiti-
nib, target ABL1 according to Drugbank (accounting for the solid
lines in the diagram). We make predictions about drugs that may
target ABL1 from our model generated via the gene-disease-drug
association which must satisfy two conditions:
1) There exists a gene-disease-drug path in Chem2Bio2RDF
2) The calculated association score for the gene-drug pair
should be less than a certain threshold.
The association scores are computed using the Bio-LDA model
with 50 topics on the most recent 336899 abstracts published
recently. The association score based on the Bio-LDA model are
given by equation 8, which is also known as the symmetric KL
divergence. We used the score not larger than 5 as the threshold.
Usually, there exist multiple gene-disease-drug paths in Chem2-
Bio2Rdf for a given gene-drug pair. The accumulated score of
each pair in the path is used to rank the possible paths and only the
one with the most significant score will be shown in the network.
The diseases, leukemia, myeloma and neoplasm, are the most
significant diseases that associate the gene with drugs. Figure 5
shows the generated network using the Bio-LDA model. 15 drugs
are suggested by the Bio-LDA model. Similar to the directly linked
five drugs, which are used in the treatment of various cancer, those
predicted drugs are all chemotherapy related drugs. The diseases,
leukemia and multiple myeloma, are also highly associated with
the ABL1 based on our analysis.
Investigating Drug Polypharmacology
In drug discovery, a major question is how to find drug
candidates for a targeted disease. Since approximately 35% of
known drugs have more than one target, the efficacy of many
drugs is increasingly thought to come from their effect on multiple
targets, which is known as polypharmacology. Based on this
assumption, drug candidates can be identified from compounds,
which have the same multiple targets as a marketed drug. Thus,
the question of how to find drug candidate for a therapy can be
formulated as a query in our system: find all drug-like compounds
that share at least two targets with the drug that used for the
therapy. For example, if a user wants to find some drug candidates
for inflammatory and autoimmune conditions, such as rheumatoid
arthritis, he can start with the typical drug, dexamethasone, and
then search for the compounds that active the similar targets with
a activity score greater than 50 (activity score 0–100). The
graphical representation of an example of the query process is
shown in the following Figure 6.
To further understand the relation between the given drug,
dexamethasone, and the found compound, hydrocortisone, we
Figure 4. An illustration of bio-relationships generated from selected topics.
doi:10.1371/journal.pone.0017243.g004
Table 7. Calculated association score for Venlafaxine and
HTR1A, HTR2A.
Bio-terms Co-occurrence Bio-LDA
Venlafaxine , HTR1A 211.76 0.34
Venlafaxine , HTR2A 212.72 4.0
doi:10.1371/journal.pone.0017243.t007
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within our Chem2Bio2Rdf. 47 near-shortest paths are found from
hydrocortisone to dexamethasone including 5 types, drug-gene-
drug, drug-disease-drug, drug-gene-gene-drug, drug-gene-disease-
drug, and drug-disease-gene-drug. Those near-shortest paths are
then ranked based on the association scores calculated using
equation 10. The top 10 paths and the association scores for each
pairs (based on 50 topics) are shown in Figure 7. As shown in
graph, three similar gene targets, NR3C1, ANXA1 and NOS2 are
shared by both dexamethasone and hydrocortisone. Among those
paths, five paths are associated with NR3C1, Glucocorticoid
receptor, which indicates its significant role in understanding
pharmacokinetic of drugs.
Table 9 shows the entropy of the two drugs and three gene
targets calculated based on the Bio-LDA model with 50, 100 and
200 topics using the recent 336,899 MEDLINE abstracts, which
contain 13,338 identical bio-terms. Here n represents the number
of abstracts that contain the given bio-terms in the literature set.
Dexamethasone is a more effective drug when compared to
Hydrocortisone, since it is involved in 742 more abstracts and has
higher entropies. This makes sense from a biological point of view
as dexamethasone is 40 times more potent than hydrocortisone.
Table 10 shows the symmetric KL divergence for pairs of bio-
terms in this use case, and n shows the number of co-occurrence of
the given bio-term pair. Hydrocortisone and dexamethasone co-
occurred in 17 abstracts and have lower KL divergence.
Hydrocortisone and dexamethasone target genes NR3C1,
ANXA1, and NOS2. Thus what do the entropy and KL
divergence indicate about the features of those two paths? For
different number of topics (T=200, T=100, and T=50), Table 9
shows that these ascending order of the values of average entropy
for the three genes is: ANXA1,NR3C1,NOS2, suggesting
NOS2 tends to be involved with more topics while ANXA1 tends
to be associated with less topics. Thus the path between the two
drugs with ANXA1 is more focused and specific, which intuitively
conveys more meaning. This makes sense as hydrocortisone and
dexamethasone are involved in de novo synthesis of ANXA1 gene
(Mulla, A, et. al, 2005). Thus the three paths involved with the
three genes can be ranked according to their semantic specificity
as: path with ANXA1.path with NOS2.path with NR3C1.
Moreover, the smaller the KL divergence of the path is, the more
semantically relevant are the nodes and edges along the path.
Table 10 shows that the entities and relationships along the path
through NR3C1 are the most relevant to each other of the three
paths. Combining entropy and KL divergence, the path with
ANXA1 is more favorable in specific research and the path with
NR3C1 is more favorable in general research.
Figure 5. The association network for Tyrosine-protein kinase ABL1 based on the Bio-LDA model.
doi:10.1371/journal.pone.0017243.g005
Table 8. Comparing the co-occurrence method and the Bio-
LDA in identifying associated bio-terms.
Bio-terms Chem2Bio2Rdf Co-occurrence Bio-LDA
Disease , Gene 412117 266 14895
Disease , Drug 1490 20 228
Gene , Drug 5047 28 355
Gene , Gene 7593 13 1282
doi:10.1371/journal.pone.0017243.t008
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Map
The molecular connectivity map shows how the expression level
of genes change in response to different drug compound
perturbations, which enables researchers to compare the molec-
ular therapeutic/toxicological profiles of many candidate drugs or
drug target genes, therefore improving the chance of developing
high quality drugs and reducing drug development time. In this
Figure 7. The top 10 paths obtained between Hydrocortisone and Dexamethasone.
doi:10.1371/journal.pone.0017243.g007
Figure 6. Graphic representation of the SPARQL query for finding the compound similar to Dexamethasone.
doi:10.1371/journal.pone.0017243.g006
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specific drug-gene connectivity maps, by integrating chemogenomic
sources (i.e. Chem2Bio2Rdf) with literature from our Bio-LDA
model. The purpose of the connectivity maps is finding novel
therapeutic uses of old drugs, also known as drug repositioning.
Using Alzheimer’s disease (AD) as an example, the gene list is
created by searching for AD-related genes from our linked data
(Chem2Bio2Rdf). 88 genes were identifies. 382 drugs are selected
Table 9. Bio-term entropies for nodes shown in the top 3
paths.
Bio-terms
name
Bio-terms
Identify Type n T=200 T=100 T=50 Average
Hydrocortisone DB00741 Drug 139 2.558 1.880 2.454 2.297
Dexamethasone DB01234 Drug 881 4.292 3.754 3.484 3.843
ANXA1 P04083 Gene 23 2.266 1.631 1.365 1.754
NR3C1 P04150 Gene 16 2.123 2.840 2.486 2.483
NOS2 P35228 Gene 40 2.824 2.833 2.598 2.752
doi:10.1371/journal.pone.0017243.t009
Table 10. Symmetric KL divergence for the top 3 paths.
Bio-term semantic associations T=200 T=100 T=50 Average
Hydrocortisone , NR3C1 ,
Dexamethasone
29.96 21.55 20.49 24.00
Hydrocortisone , NOS2 ,
Dexamethasone
35.40 31.00 27.42 31.28
Hydrocortisone , ANXA1,
Dexamethasone
43.39 40.31 33.20 38.97
doi:10.1371/journal.pone.0017243.t010
Figure 8. A connectivity map linking AD-related genes to significant drugs, highlighting two areas (A) and (B).
doi:10.1371/journal.pone.0017243.g008
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to 13998, and the drug list can expand to 1898 if the gene-gene
interaction is involved. Our research shows that the top ranks of
the expanded genes and drugs are close to the lists without
extension. Thus, we do not consider gene-gene interaction unless
user specified to speed up the calculation.
The connectivity scores are calculated using the Bio-LDA
association scores. Figure 8 shows the AD-related drug-protein
connectivity map. The x-dimension represents drugs and the y-
dimension represents genes. Hierarchical clustering of drugs and
genes is performed use their Euclidean distances. The color
intensity for each cell is drawn in proportion to the connectivity
score as shown in the heatmap legend. In the Bio-LDA model,
the connectivity scores indicate the distance between the gene-
drug pair. The smaller the score is, the more significant the
relationship is. The cells with purple color indicate the significant
interactions related to Alzheimer’s disease. From the figure and
zoom in boxes, we can study the genes and drugs highly related
to Alzheimer’s disease. For example, the CYP family is known to
be highly associated with AD. The discovered drug, Ketocona-
zole, may affect some AD drug metabolism, such as Donepezil.
The Diclofenac is a non-steroidal anti-inflammatory drug
(NSAID). Research shows the NSAIDs may prevent the
development of AD if given daily in small doses during many
years.
Discussion
In this paper, we describe the architecture and main features of
the Bio-LDA model. Three applications, association predication,
association search, and connectivity map generation, are presented
which we believe are useful for biomedical and drug discovery
applications, especially when combining the Bio-LDA model with
a pre-knowledge network, i.e. Chem2Bio2Rdf. We believe these
experiments demonstrate great value in performing this kind of
analysis for enhancing biological knowledge.
We demonstrate how Bio-LDA, in contrast to natural language
processing methods, can automatically derive a collection of topics
of related biological terms that map to clearly understandable
biological themes, and which allow the complexity of topics
addressed in individual papers to be represented by probabilities of
association with topics. Further, individual bioterms can be
associated with topics with a given level of probability, and
through the KL Divergence measure, a distance between any two
terms can be generated via their probabilities of association with
topics. This opens up the possibility of using the method for
ranking paths through the data, or for an alternate way of
measuring degree of association between, for example, drugs and
genes, or pathways and diseases.
Our examples indicate that the topics created using Bio-LDA
are surprisingly succinct in identifying the bioterms associated with
particular topic areas. Our comparison of Bio-LDA with a
standard LDA model showed that the models created by BioLDA
are distinctly different from standard LDA and indicate that the
use of bioterms only is useful in defining crisp clusters. Further, our
case studies pertaining to drug targets and drug polypharmacology
and indicate that when combined with methods for finding paths
between entities, highly relevant results can be obtained (for
example, finding potential drugs for a target or compounds with
similar polypharmacology). Finally we show how Bio-LDA can be
used to increase the utility of molecular connectivity approaches
such as heatmaps.
Our experiment used 336899 recent MEDLINE abstracts. The
performance of various LDA and extended LDA implementations
is computationally expensive, motivating efforts to improve
scalability. As the underlying algorithms for various implementa-
tions differ, the efforts to improve scalability have also differed
[19,28,29]. In order to run our model in all 18 million papers in
PubMed, a scalable model, such as the parallel Bio-LDA model, is
required. We plan to investigate the PLDA implementation of
Wang et al with Bio-LDA, using the Map Reduce implementation
[19]. By making larger collections available for analysis, we hope
to expose better and more complex relations.
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